Mangoceuticals, Inc. (MGRX)
Nasdaq: MGRX · Services-Misc Health & Allied Services, NEC · Dallas, TX · filing with the SEC since 2022
Filings
198 filings since 2017 beside 45 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Feb 18, 2025.
Filings a yearinsider forms included
1064627136
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 16 times in the last 36 months, the newest Jul 30, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Feb 6, 2026.SEC letters: 15 in the last 36 months, the newest Jan 27, 2026.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026
8-K items 5.07, 5.08, 8.01
Shareholder vote; item 5.08; Other event · Current report
Nov 2, 2026
Oct 1, 2026
8-K items 1.01, 2.01, 3.02, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Sep 30, 2026
Jul 30, 2026
8-K items 1.01, 5.02, 5.03, 7.01, 9.01
Major agreement signed; Officer or director change; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Jul 28, 2026
Jul 2, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Jun 29, 2026
Mar 17, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Mar 16, 2026
Dec 19, 2025
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Dec 18, 2025
Dec 19, 2025
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Dec 17, 2025
Dec 10, 2025
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Dec 4, 2025
Oct 29, 2025
8-K items 1.01, 1.02, 2.03, 3.02, 5.02, 9.01
Major agreement signed; Major agreement ended; New debt or obligation taken on; Shares sold without registration; Officer or director change · Current report
Sep 15, 2025
40 of 198 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.